美国 · 股市与财经 · Yahoo Finance

Iambic Therapeutics (IAM) Filed An IND For IAM217

来源：Yahoo Finance · 美国 10 小时前

Iambic Therapeutics (NasdaqGS:IAM) submitted an Investigational New Drug application to the FDA for IAM217, a KIF18A inhibitor, in October 2026. IAM217 is described by the company…

在 Yahoo Finance 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finance.yahoo.com)

Iambic Therapeutics (IAM) Filed An IND For IAM217

推荐阅读

Tether backs AIsa as strategic investor, completing seed extension round

Why hedge funds could be making a bond market shock more likely

Americans are packing town halls to stop data centers. It's working, for now

France is aflame as peaceful protests over the cost of living devolve into chaos and looting

Circle defends USDC economics as stablecoin rivals court its partners with bigger cut

New England faces record-high heating oil costs this winter

Iambic Therapeutics (IAM) Filed An IND For IAM217

分享

推荐阅读

Tether backs AIsa as strategic investor, completing seed extension round

Why hedge funds could be making a bond market shock more likely

Americans are packing town halls to stop data centers. It's working, for now

France is aflame as peaceful protests over the cost of living devolve into chaos and looting

Circle defends USDC economics as stablecoin rivals court its partners with bigger cut

New England faces record-high heating oil costs this winter